The pharmacological treatment of obesity: A historical perspective

dc.creatorGarcía Pacheco, Andrea Verónica
dc.creatorArévalo Peláez, Carlos Eduardo
dc.creatorOrtiz Benavides, Rina Elizabeth
dc.date2022-07-23
dc.date.accessioned2022-10-28T12:07:56Z
dc.date.available2022-10-28T12:07:56Z
dc.identifierhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24172
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4955999
dc.descriptionObesity is a highly prevalent disease associated with several metabolic pathologies such as diabetes, hypertension, metabolic syndrome, hepatic steatosis, and different types of cancer. However, since 1933, when the first pharmacological treatments for obesity appeared, their effectiveness and safety have been questioned, leading to the withdrawal of several drugs from the market. Currently, five drugs have been approved by the Food and Drug Administration (FDA) and are still in use for obesity control, of which GLP-1 analogs have demonstrated a better safety profile and moderate efficacy in reducing body weight. This literature review presents a historical analysis of anti-obesity drugs, focusing on their efficacy and adverse effects.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherAcademia Nacional de Medicina venezolana.es-ES
dc.relationhttp://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/24172/144814490526
dc.rightsDerechos de autor 2022 Gaceta Médica de Caracases-ES
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0es-ES
dc.sourceGaceta Médica de Caracas; Vol. 130 Núm. 3S (2022)es-ES
dc.source2739-0012
dc.source0367-4762
dc.subjectObesityes-ES
dc.subjectanti-obesity drugses-ES
dc.subjectanti-obesity agentses-ES
dc.titleThe pharmacological treatment of obesity: A historical perspectivees-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.coverageColombiaes-ES


Este ítem pertenece a la siguiente institución